Connexin 43 expression predicts poor progression-free survival in patients with non-muscle invasive urothelial bladder cancer

OBJECTIVES: To evaluate the protein expression of connexin 43 (Cx43) in primary urothelial bladder cancer and test its association with the histopathological characteristics and clinical outcome. METHODS: A tissue microarray containing 348 tissue samples from 174 patients with primary urothelial car...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Clin Pathol
Egile Nagusiak: Poyet, Cédric, Buser, Lorenz, Roudnicky, Filip, Detmar, Michael, Hermanns, Thomas, Mannhard, Doris, Höhn, Andrej, Rüschoff, Jan, Zhong, Qing, Sulser, Tullio, Moch, Holger, Wild, Peter J
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BMJ Publishing Group 2015
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4602233/
https://ncbi.nlm.nih.gov/pubmed/26251520
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jclinpath-2015-202898
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak